The mouse (Mus musculus) is the premier animal model for understanding human disease and development. Here we show that a comprehensive understanding of mouse biology is only possible with the availability of a finished, high-quality genome assembly. The finished clone-based assembly of the mouse strain C57BL/6J reported here has over 175,000 fewer gaps and over 139 Mb more of novel sequence, compared with the earlier MGSCv3 draft genome assembly. In a comprehensive analysis of this revised genome sequence, we are now able to define 20,210 protein-coding genes, over a thousand more than predicted in the human genome (19,042 genes). In addition, we identified 439 long, non–protein-coding RNAs with evidence for transcribed orthologs in human. We analyzed the complex and repetitive landscape of 267 Mb of sequence that was missing or misassembled in the previously published assembly, and we provide insights into the reasons for its resistance to sequencing and assembly by whole-genome shotgun approaches. Duplicated regions within newly assembled sequence tend to be of more recent ancestry than duplicates in the published draft, correcting our initial understanding of recent evolution on the mouse lineage. These duplicates appear to be largely composed of sequence regions containing transposable elements and duplicated protein-coding genes; of these, some may be fixed in the mouse population, but at least 40% of segmentally duplicated sequences are copy number variable even among laboratory mouse strains. Mouse lineage-specific regions contain 3,767 genes drawn mainly from rapidly-changing gene families associated with reproductive functions. The finished mouse genome assembly, therefore, greatly improves our understanding of rodent-specific biology and allows the delineation of ancestral biological functions that are shared with human from derived functions that are not.
The availability of an accurate genome sequence provides the bedrock upon which modern biomedical research is based. Here we describe a high-quality assembly, Build 36, of the mouse genome. This assembly was put together by aligning overlapping individual clones representing parts of the genome, and it provides a more complete picture than previous assemblies, because it adds much rodent-specific sequence that was previously unavailable. The addition of these sequences provides insight into both the genomic architecture and the gene complement of the mouse. In particular, it highlights recent gene duplications and the expansion of certain gene families during rodent evolution. An improved understanding of the mouse genome and thus mouse biology will enhance the utility of the mouse as a model for human disease.
Citation: Church DM, Goodstadt L, Hillier LW, Zody MC, Goldstein S, et al. (2009) Lineage-Specific Biology Revealed by a Finished Genome Assembly of the Mouse. PLoS Biol 7(5): e1000112. doi:10.1371/journal.pbio.1000112
Academic Editor: Richard J. Roberts, New England Biolabs, United States of America
Received: December 19, 2008; Accepted: April 3, 2009; Published: May 26, 2009
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: DMC, RA, JC, MD, DM, WH, YK, and the National Institutes of Health Intramural Sequencing Center were supported by the Intramural Research Program of the NIH. CPP, ZB, and LG were supported by the UK Medical Research Council. ACM was supported by the Swiss National Science Foundation. EEE, XS, and ZC were supported in part by National Institutes of Health grant HG002385. EEE is an investigator of the Howard Hughes Medical Institute. The Genome Center at Washington University, The Human Genome Sequencing Center at the Baylor College of Medicine, and The Broad Institute of Harvard and MIT are supported by genome sequencing grants from National Human Genome Research Institute. Chromosomes 2, 4, 11 and X were completed with funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: EST, expressed sequence tag; ncRNA, noncoding RNA; SSR, simple sequence repeat; TPF, tiling path file; VR, vomeronasal receptors; WGSA, Whole Genome Sequence and Assembly
The mouse (Mus musculus) occupies a singular position in genetics and genomics. It is both the premier animal model for human disease and development and the mammalian genome against which human DNA, genes, and genomes are most frequently compared. Despite approximately 90 million years of independent evolution , the laboratory mouse remains an excellent model for many human phenotypes and thus is critical to the study of human disease and mammalian development. Its small size and rapid breeding cycle are of immense practical utility, and the mature mouse genetics system, with hundreds of inbred lines, allows phenotypic consequences of sequence variation to be inferred .
Given the critical role of the mouse as a model organism, it is particularly important to separate shared ancestral characteristics that have been conserved in the mouse and human since their divergence from derived characteristics that are unique to either lineage. Mouse and human genes whose coding sequences have scarcely changed since the last common ancestor and that have remained unduplicated in each lineage are the most likely to have retained their ancestral functions. In contrast, genes that have duplicated along the rodent lineage may contribute to derived traits that are less relevant to human biology, and are thus less appropriate models of human physiology and disease.
Genomic duplication and divergence is a primary source of functional innovation . Recent gene duplicates are highly sequence-similar and are expected to be embedded within segmentally duplicated regions of the genome (defined as DNA segments greater than 1 kb showing >90% sequence identity ). Approximately 40% (50 Mb) of segmentally duplicated sequences are known to be copy number variable among laboratory strains , whereas the remainder appears to have been fixed, either by genetic drift or by positive selection when the duplicated genes provide a selective advantage ,. Past episodes of positive selection upon codon substitutions can be inferred from evolutionary analyses of segmentally duplicated and lineage-specific genes –.
In late 2002, we published a draft mouse genome assembly, referred to as the MGSCv3, of a single, inbred strain (C57BL/6J, or “B6”) . This publication marked a watershed in mammalian genetics and genomics, as it allowed the first genomic comparisons between mouse and human. It also represented the first publicly funded mammalian genome project using Whole Genome Sequence and Assembly (WGSA). This approach, or variations of it, has since been the primary method for producing most mammalian genomes – (Figure 1).
A careful cost/benefit analysis must be performed when approaching a genomic sequencing project. If lineage-specific biology is important, clone-based finishing of some form will be required.
Despite the great utility of the initial MGSCv3 assembly, the draft genome contained over 176,000 gaps and included entire regions whose positions and/or orientations in the assembly now appear to have been in error. The most serious issue to the use of the MGSCv3 is its almost complete lack of highly sequence-similar and recently segmentally duplicated regions ,. It was our principal concern that missing segmental duplication-rich regions of the draft assembly might harbour large numbers of rapidly evolving genes whose identification might illuminate mouse-specific biology. Only by accounting for these missing genes could we obtain a comprehensive understanding of the biology that distinguishes these two species. Given this, it has been a goal of the international consortium to produce a mouse genome assembly of coverage and quality comparable to that of the human genome described in 2004 . Although it was anticipated that the effort and expense required for producing such an assembly via a clone-based approach would be substantial, this would be justified by the increased fidelity, and thus utility, of the higher quality genome assembly to the biomedical research community.
Here we report the completion of this effort and present a high-quality, largely finished clone-based genome assembly of the C57BL/6J strain of mouse, here referred to as Build 36. This new assembly includes 267 Mb of sequence (Protocol S1) that was either missing or misassembled, much of which consists of repetitive and segmentally duplicated sequence (4.94% of the genome). Over 175,000 gaps in MGSCv3 have been closed, and genome-wide continuity has improved accordingly, with scaffold N50 lengths (the scaffold length in which at least half of the bases of the assembly reside) increasing from 17 Mb to 40 Mb.
The availability of finished sequence for human, and now mouse, enables more-complete surveys of protein-coding genes in both species. We now estimate that mouse and human reference genomes contain 20,210 and 19,042 protein-coding genes, respectively. The number of mouse genes had been missing or substantially disrupted in the previous MGSCv3 assembly is 2,185. The majority of these arise from rodent lineage-specific duplications, often (61%) embedded within segmentally duplicated regions that were recalcitrant to WGSA. Many of these mouse-specific genes may contribute to rodent-specific functions and, with their inclusion in the assembly, are now available for further investigation.
Build 36 Assembly
The mouse genome assembly (Build 36; Box 1) shows marked improvements over the MGSCv3 (Table 1) (Tables S1, S2, S3, S4, S5 and S6 in Protocol S1), with an increased amount of ordered and oriented sequence placed on a chromosome (2.58 Gb in the MGSCv3 versus 2.64 Gb in Build 36) and increased base level accuracy due to the addition of clone-based finished sequence (Figure 2) (Table S3a–S3c in Protocol S1). Scaffold continuity, as measured by the N50, is also dramatically improved, with an N50 of 40.3 Mb in Build 36 compared to an N50 of 17.8 Mb in the MGSCv3. In addition, the number of gaps in Build 36 is reduced by over 140-fold when compared to the MGSCv3 (Table 1) (Tables S4 and S5 in Protocol S1). Evidence (Box 1) indicates that Build 36 is a high-quality assembly that covers >99% of the C57BL/6J genome (assuming a 2.66-Gb genome size; see Protocol S1). Although many of the problematic regions identified in these analyses have been corrected in a subsequent Build 37 (the current public build, see Box 1 and Protocol S1), a few regions remain under review and will be addressed in forthcoming assemblies. Improvements to the assembly are evident at a fine scale in the spanning of previous gaps and inclusion of locally duplicated sequences. However, at a larger scale, the genome structure remains basically unchanged from MGSCv3, and conserved syntenic relationships to human inferred from the two assemblies have remained essentially unaltered (Figure 3).
Box 1. Assembly Production and Quality Assurance
The mouse genome assembly (Build 36) was produced largely as described previously  but with some variations in methodology and standards (Protocol S1). The availability of a high-quality WGS assembly was essential in providing a framework for the clone-based assembly. Nevertheless, over 7% of the bases found in the finished clone sequences failed to align to the MGSCv3. Unaligned sequence contributed from approximately 4% for Chromosome 11 to 18% for the X chromosome (Protocol S1: Alignments)). Tables S1, S2, S3, S4 and S5 in Protocol S1 provide assembly statistics, stratified by chromosome, for both Build 36 and the subsequent Build 37, which was produced after the analysis performed here. While this analysis led to improvements in Build 37, the changes in this build are not expected to drastically alter the conclusions of the analysis presented in this manuscript. The main differences between Build 36 and Build 37 are the incorporation of an additional 8.3 Mb of sequence onto the assembled chromosomes and 44.7 Mb of sequence as unplaced sequence. During the course of analyzing Build 36, a number of scaffolds that were unplaced in the MGSCv3 were found to contain sequences not represented in Build 36. In all cases, these sequences contained protein-coding genes. While many of these can be associated with a chromosome, the exact order and orientation is unknown. However, because of the missing gene sequences, we thought it was important to release Build 37 with these sequences included. Work is ongoing to both place these sequences in the correct location on the chromosome and to identify clone-based sequences to represent them. Although statistics are provided for the Y chromosome, analysis of this chromosome will not be discussed here, because it remains a separate project that will be described at a later date. However, the authors have generously provided the scientific community with data prior to publication (J. Alfoldi, personal communication).
To assess the accuracy of Build 36, the genome assembly was compared to several independent sources of data including a linkage map , a radiation hybrid map , and sequences (genomic and transcript based) not used to generate the assembly . In all cases, the discrepancy rate was very low, indicating that Build 36 is a high-quality and high-coverage genome assembly (Protocol S1). This project was the first to use an optical map to assess the assembly and to disambiguate problematic regions. We assembled a genome-wide SwaI restriction map of the C57BL/6J mouse genome using single-molecule ordered restriction maps obtained from the optical mapping system –. This optical map showed 99% concordance with the restriction endonuclease digest pattern predicted by the genome assembly. We identified 423 discordant sites which were manually evaluated; in 95 cases, the optical map was judged to be correct, in 220 cases the sequence as determined to be correct and the remaining 108 cases were ambiguous (Protocol S1). The optical map provided critical data for clone placement in several repetitive regions, such as the beta-defensin region on mouse chromosome 8 (Figure S66 in Protocol S1), as well as providing evidence for clone order in regions where there was little other information, such as some pericentromeric regions. In addition, the optical map covers roughly two-thirds of the 103 unspanned gaps in Build 36 (Protocol S1: Comparison of Optical Map to Build 36 (pdf)) and will be used in future builds to provide more accurate gap estimates.
Chromosomes are drawn to scale, with MGSCv3 to the left (green) and Build 36 to the right (purple). A female mouse provided the DNA for the MGSCv3, so no Y chromosome was available for this assembly.
The chromosomes of human Build 36 are painted with segments of conserved synteny ≥300 kb long with mouse MGSCv3 (left) and Build 36 (right). Colors indicate mouse chromosomes (see legend bottom right), while lines indicate orientation (top left to bottom right is direct, top right to bottom left is inverted). White regions are not covered by alignments forming a segment ≥300 kb. Red triangles are human centromeres. Note that all undirected blocks (regions of identical color) are identical between the two mouse builds except a region at the centromere of human Chromosome 9, which is itself an artifact in the MGSCv3 map. However, several areas of orientation change, some quite small, can be seen.
We identified a total of 334 chromosomal breakpoint intervals between human and mouse and refined the breakpoints to an average interval length of 335 kbp. We found that 50% (167/334) of the breakpoints and that 28.7% by base pair (32.2/111.9 Mbp) intersected with segmental duplications. This 6-fold enrichment is significant (p<0.0001) by simulation (n = 10,000 replicates). Using data from rat, mouse, and human, we further categorized the breakpoint intervals as mouse-specific (n = 18), contiguous with rat (n = 276), or ambiguous (n = 40). The latter category frequently shared only one of the two breakpoints between mouse and rat, suggestive of breakpoint reuse . While all three categories are significantly enriched in segmental duplications, we found the majority of mouse-specific breakpoints (16/18 or 89%) and ambiguous rat–mouse (37/40 or 93%) breakpoints harbored segmental duplications. These data strongly support the now longstanding observation that chromosomal rearrangements preferentially associate with regions enriched with duplicated sequences ,–.
Newly Assembled Genomic DNA Consists Mostly of Lineage-Specific Sequence
The revised Build 36 assembly contains 139 Mb of sequence that could not be aligned against, and thus appears to have been absent from, the previous MGSCv3 draft assembly. 108 Mb (77%) of this sequence consists of 119,000 repetitive elements (Table S7 in Protocol S1); this was expected because highly sequence-similar repetitive sequences are particularly difficult to resolve using WGSA ,. One-third (45.2 Mb; 33%) of this newly incorporated repetitive sequence is derived from the most abundant mouse repeat, LINE1. These newly identified LINE1 copies have, on average, a markedly lower divergence from the consensus (mean 4.5%, as reported by RepeatMasker) than those that align completely to the previous MGSCv3 sequence (mean 9.4%). Hence they tend to have been inserted more recently in the mouse lineage. Insertions of LINE1s are clearly ongoing because they are known to be responsible for 10–15% of deleterious mutations ,.
Eighty percent of sequence added or corrected in the mouse genome assembly consists of segmentally duplicated regions or interspersed repeats. Most of these have now been ordered and oriented on a chromosome (Figure 4 and Protocol S1). The large amount (126 Mb; 4.94%) of segmentally duplicated sequence in the mouse genome was unexpected, because the initial MGSCv3 assembly contained virtually no (<0.1%) such sequence , and what was there in MGSCv3 resided in a large pool of unplaced sequences. When evaluating the segmental duplication content of Build 36, we used an assembly-independent approach  to validate 85–91% of long (≥10 kb) and highly similar (94–99%) duplications. Nevertheless, some virtually identical (>99%) duplications remained as artefacts in the assembly, because these exhibited slightly lower rates of validation (82%), and further work will be required to resolve them. Of critical importance, with the addition of the new data in Build 36, segmental duplications in the mouse thus are now seen to occupy a similar proportion of the genome as they do in human. However, they are overwhelmingly intrachromosomal, with a high prevalence of tandem duplication, whereas human segmental duplications are often interchromosomal .
Interchromosomal (red) and intrachromosomal (blue) duplications (>95% identity and >10 kbp) in length are shown for both genome assemblies with the requirement that pairwise alignments are shown for only those regions (Build 36) that are also confirmed by the WGS depth of coverage analysis (black vertical bars/ticks). Positions of the centromeres (acrocentric) are shown (purple) for the MGSCv3 build. Initial estimates predicted the amount of segmental duplication to be approximately 1.5–2% of the genome. Calculations performed using Build 36 suggested the amount is much higher, approximately 4.5–5%. In addition, >60% of duplicated sequences were unplaced in the MGSCv3. In Build 36, almost all are assigned to a chromosome
This is partially addressed in , but we elaborate further. When one compares the divergence of segmental duplications between the mouse (Build 36) and human genome assemblies (Build 36), there are some notable differences. For example, the majority of human intrachromosomal segmental duplications show high sequence identity (98.5–99.5% with a mode at 99% sequence identity). In contrast, the pairwise sequence identity distribution for mouse segmental duplications shows a much more bell-shaped distribution with a clear mode around 95%. These findings are consistent with a burst of intrachromosomal segmental duplications in the human–great ape lineage as recently discussed , and indicate that perhaps intrachromosomal segmental duplications have a more ancient origin in the mouse. There are, however, some important caveats. First, it is likely that high-identity duplications in the human genome assembly have been better resolved because of the larger and longer effort in its finishing—as such, we posit that we are underestimating the highest-identity segmental duplications in the mouse genome. Second, the substitution rate for rodents is significantly higher than primates, so if divergence is used as surrogate for evolutionary age, this adjustment must be taken to account. Finally, this pattern is true for C57BL6, but the pattern in wild-type mice under strong natural selection may differ significantly. Estimating differences in timing of segmental duplications is particularly tricky in the absence of comparative sequence data of more closely related rodent genomes.
Mouse and Human Protein-Coding Gene Repertoires
The Build 36 assembly contains many genes that were absent, truncated, incomplete, or misassembled in the initial draft MGSCv3 genome sequence. As we describe below, the vast majority of these genes reside in segmentally duplicated regions. Using gene predictions for human and mouse from both NCBI  and Ensembl , we retained only those that were conserved either within or between the two species. Gene models were assessed for their reliability by: (i) comparing the exon boundaries in alignments of predicted orthologous and paralogous genes, (ii) considering whether mouse and human homologues lay within regions of conserved synteny, and (iii) automatically inspecting genes for reading frame disrupting mutations . Homologues generated by retrotranspositions since the human–mouse divergence lack conserved exon boundaries and mostly lie outside of syntenic regions, and thus could be assigned as likely pseudogenes.
This process identified 20,210 high-quality protein-coding gene models in mouse and 19,042 such models in the human genome (Protocol S1, section: Protein Coding Genes and Gene Families). This number of reliable human genes is very much lower than initial reports ,, yet it compares well with three more recent estimates –. The marked discrepancy between mouse and human gene counts results mainly from contrasting rates at which these lineages have acquired gene duplicates, as we shall discuss below. The revised proportions of protein-coding sequence in the euchromatic sequence of the mouse and human genome assemblies are now found to be 1.27% (33.5 Mb out of 2.64 Gb) and 1.06% (32.6 Mb out of 3.08 Gb), respectively, rather than the approximately 1.5% often quoted.
Simple 1:1 orthologs correspond to genes that have remained intact and unduplicated since the last common ancestor of mouse and human. Using a recently developed phylogenetic approach , we could identify 15,187 human and mouse genes in simple 1:1 orthologous relationships, representing 75% of mouse and 80% of human genes. By comparison, the original survey of genes from the draft MGSCv3 assembly was only able to clearly identify 58% (12,845 out of 22,011) of mouse genes as having 1:1 orthologs in the human genome . Simple 1:1 orthologs exhibited median nucleotide and amino acid identities of 85.3% and 88.2%, respectively. These mouse and human genes differed by a median of 0.58 synonymous substitutions at synonymous sites (dS), and had a median ratio of nonsynonymous to synonymous substitutions (dN/dS) of 0.095 (Table 2).
Only eight mouse genes with 1:1 orthologs in human were entirely absent from the initial MGSCv3 assembly (see Table S8 in Protocol S1); a further 13 single-copy gene models in mouse that have been duplicated on the human lineage were also missing from MGSCv3. Nevertheless, 825 1:1 orthologs were substantially disrupted in MGSCv3: at least 25% of their exonic sequence was absent from or misplaced in the draft MGSCv3 assembly (see Materials and Methods and Protocol S1). The exonic sequences of another 3,439 1:1 orthologs were also affected by missing or misassembled sequence, albeit less drastically (see Material and Methods and Protocol S1). In total, 30% of all gene models in Build 36 would have been disrupted to some extent by errors in the MGSCv3 assembly.
Mouse (C57BL/6J)-Specific Genes
It is thus clear that while MGSCv3 had provided a largely faithful representation of unduplicated 1:1 orthologs, Build 36 provides across-the-board improvements to the quality of gene predictions. This greatly improved assembly now permits a more-complete understanding of rodent-specific genes. Of 2,185 Build 36 gene models that were substantially disrupted by missing or misassembled sequence in MGSCv3 (see Materials and Methods), 1,259 (58%) are mouse lineage-specific duplicates (Figure 5). Similarly, of 242 genes that fell entirely within gaps in the previous MGSCv3 assembly, 221 (91%) are mouse-specific duplicates; 90% of the 331 gene models that were in previously unplaced sequences in MGSCv3, but correctly assembled in Build 36, are also mouse-specific duplicates. Conversely, of the genes that were only duplicated on the human but not the mouse lineage, only 101 were disrupted in MGSCv3. The repetitive genomic regions in the mouse (an example of which can be found in Figure 6) thus presented a considerable challenge to sequencing, assembly, and gene prediction.
Mouse lineage-specific gene duplicates are shown in red, and all other genes are shown in blue. The large number of mouse-specific genes that are entirely missing, truncated, or otherwise disrupted in MGSCv3 underscores the value of the finished Build 36 assembly in understanding rodent-specific biology.
(A) The upper left hand corner shows a dot-matrix view of the Build 36 Chromosome 5 (horizontal axis) aligned to the MGSCv3 Chromosome 5 (vertical axis). The triangle marks the portion of the chromosome shown in the zoomed in view. The axes are in the same orientation. 1.5 Mb of sequence that was absent from MGSCv3 has been included in Build 36. This region contains 30 Pramel genes (shown in red) and approximately an additional 20 Pramel pseudogenes (in blue). This region consists almost entirely of segmental duplications (represented by blue lines below the dot matrix), which previously confounded the WGA algorithm. Gene models for Build 36 are displayed below the dot matrix view. SD, segmental duplication; CDS, coding regions; pseudo, pseudogenes. (B) Although the orthologous PRAME and Pramel gene families have expanded independently in the primate and rodent lineages, positive selection has been most intense on equivalent regions of their structures. Positive selection on amino acid substitution has been most intense on one exterior surface (left) and has been virtually absent from the alternate face (right). Amino acids predicted to have been positively selected among human HSA1 PRAME genes (shown in red), mouse MMU4 Pramel (blue), or rat RNO5 Pramel (purple) genes have been mapped onto an homologous structure (Protein Databank code 2BNH). Amino acids that are positively selected in two or more species are shown in yellow. Three positively-selected sites among mouse Pramel genes are not highlighted, as they occur within insertions relative to the 2BNH sequence.
Of the ten gene families that have seen the greatest expansions over the mouse lineage, we find that all but two are associated with reproductive functions (Table 3). Approximately half of these genes overlap gaps in the previous MGSCv3 assembly (Figure 5). These ten families include genes with spermatid- or oocyte-specific expression, and large families of vomeronasal receptors (VRs). This suggests that conspecific competition may have driven much adaptive change in rodent gene repertoire and genome landscape.
Gene duplicates in the rodent lineage far out-number those in the primate lineage (3,767 in mouse and 2,941 in human). In general, despite particularly fast rates of protein evolution , their low sequence divergence at synonymous sites implies that they have been only relatively recent additions to the mouse lineage (Figure 7). This increased number of genes in mouse compared to human is, for most families, primarily attributable to gains in the rodent lineage; however, the primate lineage has also experienced substantial losses of genes encoding olfactory receptors, VRs, VR-associated molecules, and putative pheromones – (Figure 7). Four of the gene families with the largest rodent-specific expansions (Table 3) encode VRs, all of which are concentrated within large segmentally duplicated regions. The concentration of VRs and predicted pheromones  on Chromosome 7 contributes to this chromosome's 2.7-fold enrichment in segmental duplications . Approximately half of all gene duplication events that we observe in mouse appear to have occurred since the time of its divergence from the rat lineage approximately 12–14 million years ago (Mya) (Figure 7) .
Evolutionary time is estimated using dS (the number of synonymous substitutions per synonymous site) and a divergence time of 91 million years. The greater number of genes in the mouse compared with the human genome is largely accounted for by the lower rate of olfactory and vomeronasal receptor gene duplications (red) in the primate lineage.
Gene duplications have caused large expansions of gene families in primates as well, several of which were highlighted in the manuscript describing the finishing of the human genome . Differences in the human and mouse gene repertoires can also arise from gene loss in the rodent lineage. Genes that are associated with Mendelian disease in human can be presumed to have critical functions, and examples of their loss in the mouse are, therefore, rare and unexpected. One such case is the human gene EYS (Entrez Gene (http://www.ncbi.nlm.nih.gov/gene/) GeneID 346007), whose disruption results in retinitis pigmentosa; nevertheless the mouse ortholog found in B6 is a pseudogene . For the few human genes whose mouse orthologs are entirely absent from the current assembly, it is difficult to determine whether their absence reflects past deletions of genomic sequence or else indicates regions that continue to be problematic to sequence. One gene that has remained elusive since the draft MGSCv3 assembly is the mouse ortholog of human KAL1 (GeneID 3730), whose disruption leads to an absence or hypoplasia of olfactory bulbs and tracts in human patients . No transcript or genomic evidence for the existence of a KAL1 mouse ortholog is apparent. In fact, it has been suggested that the entire genomic region surrounding the KAL1 gene, which is adjacent to the pseudo-autosomal boundary in Xp22, in human is absent from the mouse genome . However, this genomic region is not stably propagated in bacteria  and may, in fact, vary amongst strains . Evidence of mouse orthologs for some genes in this genomic region does exist within transcript sequences that are derived from strains other than C57BL/6J –.Completing the catalogue of mouse genes and pseudogenes and understanding their homology relationship with human genes requires additional sequence from more than a single strain.
More rarely, a mouse gene may lack an apparent human ortholog simply because rapid evolution renders any similarity in their sequences undetectable. This is the case with human AU022751 (Mouse Genome Informatics (MGI; http://www.informatics.jax.org/) ID: 2147968; GeneID 102991) and mouse EG624310 (MGI: 3644796 ; GeneID 624310) that lie in conserved synteny on their X chromosomes: they are orthologous, yet show only residual and nonsignificant sequence similarity in database searches. The mouse genome contains a further ten mouse paralogs of EG624310 (MGI: 3644796 ; GeneID 624310) on a separate region of chromosome X that was largely absent from MGSCv3. AU022751 (MGI: 2147968; GeneID 102991) is of unknown function, but its mouse orthologs appear, from the expression profile of expressed sequence tags (ESTs), to be expressed frequently in oocytes and exhibit evidence for positive selection on amino acid substitutions (unpublished data). This demonstrates how apparently lineage-specific gene families can emerge by unusually rapid sequence divergence, driven in part by positive selection, over only tens of millions of years, and is a prominent example of the novel biology that can be discovered using a high quality mouse genome assembly.
Mouse Gene Family Expansions and Reproduction
The largest rodent-specific expansions have occurred among sperm-associated glutamate (E)-rich (Speer) genes on Chromosomes 5 and 14. Most Speer genes appear to have roles in spermatogenesis , but some Speer-homologous genes, termed α-takusans, are expressed in the mouse brain and regulate synaptic activity . Speer/α-takusan genes are absent from nonrodent genomes because they arose via a partial gene duplication of Dlg5 (MGI: 1918478; GeneID 71228) , followed by multiple duplications and sequence diversification, early in the rodent lineage. Many (24) of these Speer homologues were absent from or disrupted in the MGSCv3 because of earlier assembly problems associated with their repetitive nature. Assembly gaps remain within Build 36 Chromosome 14, hinting at yet more undiscovered Speer genes.
Members of the preferentially expressed antigen of melanoma (PRAME) gene family made up the third largest gene family with mouse specific expansions. All 90 mouse Prame-like (Pramel) genes were the result of duplications after the divergence of the rodent and primate lineages , and the majority of these were also incomplete in MGSCv3 (Figure 6). In primates, this family has also seen much independent expansion, and it is highly divergent in copy number both between species and within the human population ,. In rodents, Pramel gene duplications occurred not only locally, in cis, but also by translocation of a single Pramel gene from the ancestral Chromosome 4 to Chromosome 5, with additional cis-duplications there subsequently. A further segmental duplication, absent in the rat, seeded continued expansion of this gene family within chromosome 5 (Figure S1 in Protocol S1). There is abundant evidence for past episodes of positive selection within rodent Pramel and primate PRAME genes (Figure 6) . Little is known of the functions of mouse Pramel genes, except that they are often expressed in oocytes, in early embryos, and in spermatogonia .This expression profile suggests that they might perform important mitotic roles in rapidly dividing cells.
Extensive duplications within two further gene families have been restricted to X and Y chromosomes (Table 3). These families derived originally from ancestral autosomal paralogs: Sycp3 (MGI: 109542; GeneID 20962) on Chromosome 10 , and Spin1 (MGI: 109242; GeneID 20729) on Chromosome 13 . Sycp3 (MGI: 109542; GeneID 20962 ) gave rise to Slx (MGI: 99543; GeneID 664829) and Sly (MGI: 382301; GeneID 382301) genes on the X and Y chromosomes, respectively. The Spin1 homologues on the sex chromosomes, including EG546176 (MGI: 3645924; GeneID 546176) and Ssty1 (MGI: 1314663; GeneID 20611), appear to have arisen through retro-transposition and subsequent duplication. Nevertheless, the maintenance of open reading frames over the long evolutionary distances separating the divergent X and Y copies suggest that protein coding potential has been maintained for many of these genes. The expression of both gene families is specific to spermatids ,. Translocation to the sex chromosomes and subsequent widespread duplications may reflect advantages when these genes are hemizygous in males  or when gender conflict affects the sex ratio of mouse progeny . Multiple copies of these genes may act to avoid X inactivation  or help to compensate for lack of recombination on the Y chromosome .
We found that many genes in the four families described above—namely Speer, Pramel, Slx/Sly, and EG546176/Ssty1—have experienced extensive positive selection upon amino acid substitutions (unpublished data), suggesting that duplication events were themselves fixed preferentially in ancestral mouse populations. The preponderance among rodent-lineage specific genes of those with reproductive function provides an indication of the prominent role of conspecific competition in shaping the mouse gene repertoire and hence its biology . Despite their large number and the important roles that they have played in the emergence of the laboratory mouse, these genes are poorly represented among current gene catalogues. This is because they are generally found as multiple tandem copies in segmentally duplicated genomic regions, accompanied by significant numbers of gene fragments and pseudogenes. Only now, with the availability of a high-quality finished mouse genome, can the crucial roles of these rapidly evolving genomic regions in determining lineage-specific biology be fully appreciated.
Mouse Non–Protein-Coding RNA Genes
The transcribed and functional portion of the mouse genome consists of noncoding as well as protein-coding genes. Hundreds of microRNA loci, for example, have been detected within recent mouse genome assemblies . In addition, thousands of long noncoding RNAs (ncRNAs) have been detected from full-length mouse cDNA libraries ,. The contribution of these long ncRNAs to mouse biology, however, remains a matter of extensive debate. Evolutionary studies have yet to contribute to this debate by distinguishing long ncRNAs that have single human orthologs from others that have duplicated, or else emerged de novo, on the mouse lineage.
Evidence for conserved transcription is apparent for only a small proportion of long mouse ncRNA sequences, in contrast to protein-coding genes. Of 3,051 well-documented mouse long ncRNA sequences , only half (1,538 of 3,051; 50.4%) can be mapped to the human genome assembly using cross-species genomic alignments. This proportion is slightly higher than the fraction (39%) of all mouse nucleotides that have been aligned to the human genome assembly. Of these 1,538 mapped sequences, only 439 (14% of 3,051) have EST or cDNA evidence for orthologous transcription in human. Although most mouse long ncRNAs lack evidence of human expression, the minority with conserved expression represents a statistically significant (p<10−3) 9.5-fold enrichment over what is expected from random genome sampling. These 439 ncRNAs have a median length of 1,920 bp and are significantly less likely to contain annotated repetitive sequence (13% of nucleotides overlap mouse repeats) than either random intergenic regions ( 45%, p-value<0.001) or their nonconserved counterparts (25%, p-value<0.001). These mouse ncRNAs should now be prioritized for further experimental scrutiny. The remaining mouse long ncRNAs that appear to lack human orthologs may represent rodent-specific biology, transcriptional noise, or transcribed noncoding sequence that remains, as yet, unidentified in humans.
Mouse Strain-Specific Genomic Sequence
Rodent lineage-specific sequence includes regions that are copy number variable among laboratory mouse strains. Indeed, many of the largest rodent-specific gene families are known to be copy number variable among mouse strains  including Slx, V1R, and V2R family genes. We used read pair data to identify larger scale structural events in Build 36. Read pairs from nine non-B6 strains identified 2,573 sequence differences where B6 contains an insertion relative to the other strains, at least 263 of which appear to be at least 10 Kb in size. Notably, 604 events were identified that define potential deletions in B6 relative to other strains, including deletions to the pseudo-autosomal region of the X chromosome. These deletions would represent sequence present in the mouse population but absent from the reference genome. In contrast, using C57BL/6J read pairs as a negative control, we observed only 96 possible insertion events, 42 possible deletion events, and 67 possible inversion events (Table S9a and S9b in Protocol S1). Clearly, to move towards a comprehensive catalogue of CNVs, and indeed all variation including quiet mutations , in Mus musculus, sequencing of additional mouse strains will be required.
The mouse genome assembly (Build 36) is now of high fidelity and completeness, and its quality is comparable to, or perhaps better than, that of the reference human genome assembly. The finished mouse genome adds over 6% additional euchromatic sequence, much of it repetitive, but includes 1,259 mouse-specific genes that were missing or grossly misassembled in the draft. Improvements to the assembly should enhance many coordinated initiatives that are exploiting the utility of the laboratory mouse for understanding human biology and disease processes. For example, an international effort to establish baseline phenotypic measurements on the 40 most commonly used strains has provided a much needed platform upon which more complex phenotypes can be assessed . Several large-scale studies have produced hundreds of models of human disease using chemical mutagenesis or random insertional mutagenesis . Other projects are underway with the goal of producing a targeted mutation in every gene in the mouse genome . As the primary organizational framework for all of these projects, it is essential that the annotated mouse genome reference sequence is as complete and accurate as possible.
The original MGSCv3 mouse draft assembly proved comparatively cheap and easy to produce. A large number of other vertebrate genomes have been sequenced to similarly deep coverage, either as aids to model organism biology or to improve our understanding of the human genome. The cost to take a genome to an equivalent finished state is typically at least four times the cost of generating the draft assemblies using traditional Sanger sequencing. Nonetheless, it is clear from our analysis of the finished mouse genome assembly that draft WGSAs will always poorly reflect lineage-specific biology. This conclusion is also supported by analysis of both the dog , and rhesus macaque genomes ,. Whereas they provide a sufficient framework for understanding the majority of the genome that lies outside of lineage-specific regions, recent, rapidly evolving parts of the genome are greatly underrepresented due to the collapse of segmental duplications and evolutionarily young repeat sequences. Finished genome sequence has proved essential to understanding the full range of biology for both the human  and the mouse genome, and will no doubt prove similarly informative for other vertebrate species.
Using next-generation sequencing technology, the cost of generating several-fold coverage of a genome drops several orders of magnitude; however, especially for large genomes; it is still not possible to generate a de novo assembly from the collection of such reads. While it is likely that de novo assembly of large genomes using next generation sequencing technologies will be achieved relatively soon, it is unlikely that these assemblies will represent these complex, lineage-specific regions any better than WGSAs generated using traditional Sanger technology. We have seen little evidence from next-generation sequence assemblies of genome or clones that segmental duplications can be adequately resolved with methods other than capillary sequencing of clones. For example, we recently completed an analysis with 96 clones, which contained structural variants and segmental duplications and, not surprisingly, those regions that remained unresolved (by 454 sequence data) were enriched in segmental duplications and large common repeats (Eichler EE, Kidd JM, Fulton RS, Chen L, Graves T, et al. unpublished data). Cost-effectiveness should not be the primary consideration for these regions. Studies of human disease and phenotypes in other organisms show conclusively that the content, copy, and structure are important. Short-read, next-generation sequencing technology, while a significant advance, will not comprehensively capture all of this complex sequence structure. Obtaining large insert clones for these regions is the key, but we need third-generation technology with longer-read lengths to assemble these complex regions accurately. Long-read technology developments  hold promise in this regard. A targeted clone-based approach to sequencing may thus be especially well justified for representative species on the lineage leading to human, comprising our closest primate lineages as well as other simians. This is because many of the critical changes that underlie biological innovations in primate lineages are likely to reside in precisely the rapidly evolving, segmentally duplicated regions that have proved so illuminating for the mouse. Coding and noncoding gene gains and losses in each lineage, and changes to their regulatory sequence, may allow us to elucidate the pressures that have shaped different regions of the human genome over recent evolutionary history. Changes in the repertoire of immune genes, for example, would help to explain the contrasting susceptibilities of primates to different pathogens and auto-immune diseases , while much of human reproductive biology and placental development, so distinct from those of rodents, may be understood in the context of changes in reproductive strategy among primates . Other laboratory models, such as the rat, or species that lie at key branch points in the evolutionary tree leading to humans, or representatives of important lineages outside the eutherian mammals, such as marsupials, birds, and fish, may be similarly justified in having a finished genome sequence.
Comprehensive Gene Lists
The greatest improvements to the mouse assembly have been to regions that are replete with rodent lineage-specific duplicated sequence. Segmental duplications that were previously found at negligible levels now constitute almost 5% of the genome. Many of these duplications harbour multiple rodent-specific genes that show a strong bias towards reproductive function. This suggests a role for either adaptive forces or clonal selection in shaping the mouse genome. The availability of these mouse genes now allows their experimental investigation.
The comparison of two finished mammalian genomes has enabled the revision of comprehensive and reliable human and mouse protein-coding gene catalogues. The 75% of mouse genes that are in 1:1 orthologous relationships with human genes are the most likely to have maintained ancestral function in both species, and are, therefore, most appropriately targeted as disease models. Phenotype data, mainly from knockouts, are already available for over 5,000 of these 15,187 genes . Other genes exist in multiple copies in the B6 genome or are polymorphic among mouse strains, and these will be more difficult to study on a gene-by-gene basis. While variation among strains suggests that some of these lineage-specific genes are not essential to development, many of these differences may contribute to phenotypic variation seen among laboratory strains. Understanding rodent-specific innovations is, therefore, critical when investigating human physiology or disease using the mouse as a model organism.
The shortcomings of the initial draft assembly are readily apparent now that a more-complete genome assembly is available. Undoubtedly these have led to incomplete or inaccurate understanding of some aspects of mouse biology. The availability of high quality genome sequence for the mouse will lead the way in dismissing some commonly held misconceptions and, more importantly, in revealing many previously hidden secrets of mouse biology.
Supplemental material and data for this paper including validated protein-coding and noncoding gene models can be found at: http://www.ncbi.nlm.nih.gov/genome/guide/mouse/Build36_Publication_Supplement).
Materials and Methods
Sequence Generation and Assembly Production
Clone-based sequence production.
Ninety-six percent of the clone-based sequence was derived from four centres, The Genome Center at Washington University in St. Louis, The Wellcome Trust Sanger Institute, The Broad Institute of Harvard and MIT, and The Genome Center at the Baylor College of Medicine (Figure S6 in Protocol S1). DNA for the BAC, fosmid, and Whole Genome libraries was obtained from The Jackson Laboratories. Information on BAC library construction (libraries RP23, RP24, CH25, and CH36) can be found at BacPac Resources . Clone sequences were obtained as previously described  with two exceptions. The availability of B6 WGS reads allowed the centres to sequence clones to a moderate level of coverage and then “steal” reads to increase the coverage. Remaining gaps were then finished as described previously . Additionally, the requirements for finishing simple sequence repeats (SSRs) in full were changed to account for the increased levels of SSRs in the mouse genome. Additional information concerning centre-specific protocols for clone assembly processes can be found in the Protocol S1: Assembly Production.
Clone sequence quality assurance.
To ensure that base level quality of the assembled clones was high, we performed a quality assurance exercise. Each sequencing centre provided the assessing centre with the clone-based shotgun traces they had produced. The assessing centre then used their internal protocols to steal reads and assemble the final insert sequences. The two sequences were then aligned, and all differences were manually assessed by an independent third party. Differences found within SSRs were not counted as true differences. The overall base level error rate was determined to be 1 error per 50,000 bp, well below the accepted finishing standard of 1 error in 10,000 bp (Table S6 in Protocol S1).
Tiling path production.
The genome assembly is driven by a tiling path file (TPF). This provides information concerning clone (component) order as well as the location and characterization of gaps. Two methods were used to obtain clone order: alignment of clone end sequences to the MGSCv3 and clone order as obtained by the mouse fingerprint map . All TPFs were stored and evaluated in a single system. Alignments between adjacent clones were produced using a script utilizing a combination of BLAST and a banded Needleman-Wunsch algorithm (Cherry J, unpublished data; Protocol S1: Tiling Path Production). Alignments having greater than 99.6% identity, no gap greater than 25 bp, and a complete dovetail alignment were “passed”. While it is expected that all clones should have an alignment of 100% identity with no gaps, in practice this rarely happens due to the difficulty of finishing SSRs. Clones not passing the above criteria were manually assessed. In some cases, manual adjustment of the alignment could produce an acceptable overlap and in other cases, a “certificate” was submitted to provide additional external evidence that the join was acceptable. For more information on join quality information Table S7 in Protocol S1.
Production of Build 36.
Using the alignments above, AGP files were generated using a program called contig_build (Cherry J, unpublished data). This algorithm takes a tiling path and a set of alignments and generates a contig sequence. It checks for internal consistency with respect to clone order on the TPF and the provided alignments. The generated switch points were selected based on the component overlaps. In a few cases, switch points were manually edited to exclude contaminant sequence or misassembled sequence in one of the components.
To ensure inclusion of as much sequence as possible, the above assembled contigs were compared to the MGSCv3 and a combined assembly was generated essentially as previously described . In this case, the MGSCv3 was used as a TPF for reconciliation of alignment conflicts. All regions where WGS sequence was incorporated were manually assessed and the most conservative path that minimized gaps was chosen. While the vast majority of sequence in Build 36 is finished (HTGS phase 3 sequence), there was a small amount of draft and WGS sequence included (Table S3a and S3b in Protocol S1). Inclusion of this sequence was necessary as some regions of the genome were recalcitrant to propagation in BAC vectors (Figure S9 in Protocol S1).
Production of conserved synteny map.
This was produced essentially as described previously .
Both Build 36 and the MGSCv3 were analyzed using RepeatMasker version open-3.1.3 with the following parameters: -w –s –no_is –cutoff 255 –frag 20000 –gff –species mouse .
Segmental duplication analysis.
This was produced as described previously .
Mouse sequence reads were obtained from the NCBI Trace Archive; quality clipped, and repeat masked using WindowMasker . Reads were then aligned to either assemble using BLAST (version 2.2.18) (-W 28 –e 0.0001 –m8 –UT –Fm –RT –nT) . Only the highest scoring alignments were retained and the highest scoring alignment had to be at least 10% larger than the second-highest alignment score. After the top scoring alignment region had been identified, the region was padded by 20 kb on either side and the read was realigned using cross-match (P. Green, unpublished data). For an alignment difference to be scored as a variation, we required a unique alignment in the genome and confirmation by more than one trace that had been sequenced in a different sequencing tray. Additional information can be found in Protocol S1: Copy Number Variation.
In order to identify variation based on mate pair violations, the BLAST alignments described above were sorted by best hit. The top scoring hits for either end that were within 200 kb of each other were retained for further analysis. If multiple locations for a clone could be identified, the clone was not kept for the final analysis. We defined a placed read pair as “satisfied” if the calculated insert size was within three standard deviations of the mean. Additional information can be found in Protocol S1: Copy Number Variation.
Gene catalogue construction.
Mouse and human gene models identified using either the Ensembl pipeline (release 43) or the NCBI pipeline (mouse Build36 v1 and human Build 36 v3) were obtained. Comparison of genomic coordinates allowed for the reconciliation of these two sets into a single gene catalogue (Protocol S1: Protein-Coding Genes and Gene Families).
The reconciled gene lists were quality assessed based on their predicted orthologous relationships as previously described  and on the conservation of exonic boundaries in the case of multi-exonic genes.
To determine genes that are missing from the MGSCv3, the Build 36 and the MGSCv3 assemblies were aligned to each other using BLAST . The alignments were trimmed to maximize alignment scores and to retain reciprocal best hits. An additional step allowed alignments that are of high quality, but not reciprocal, to be included in order to capture regions that are duplicated in one assembly, but not in the other (Y. Kapustin, unpublished data). CDS features on Build 36 were then propagated through the alignments onto the MGSv3 (J. Cherry, unpublished data) to obtain coordinates on the MGSCv3. Exonic coordinates from the union of NCBI and Ensembl transcripts for each gene were mapped through alignments from Build 36 onto MGSCv3 (J. Cherry, unpublished data). Exonic regions that abutted, or were wholly contained within, one another were merged before mapping, as were MGSCv3 aligned regions that overlapped.
We have chosen not to compare the current and initial draft mouse gene catalogues, because gene annotations have benefitted from the many improvements in the availability of transcriptional evidence, gene prediction algorithms, and the heuristics used to evaluate these data. Instead, we determined the extent to which the initial MGSCv3 assembly could have supported the current mouse gene catalogue. We were thus interested in identifying disrupted Build 36 gene models whose corresponding MGSCv3 sequence was (i) not previously placed on chromosome scaffolds; (ii) previously dispersed among two or more different chromosomes, and/or were placed on both strands of a single chromosome; (iii) interdigitated, on the same strand, with sequence corresponding with an unrelated gene model; and (iv) entirely absent from this early assembly. We describe any such gene model as being “unmatched” in MGSCv3. These four unmatched criteria were applied in order. The remaining “matched” Build 36 gene models are contiguous and their exons do not overlap with other gene models on the same strand in both Build 36 and MGSCv3 assemblies. With few (65) exceptions, these gene models are placed on the same chromosome and strand in both assemblies.
For each Build 36 gene model, we then tabulated its exonic regions according to these four unmatched criteria. This allowed us to estimate the proportion of Build 36 exonic nucleotides that could have been predicted correctly in the early MGSCv3 assembly. Build 36 gene models were deemed to be “substantially disrupted” (see Main Text: Mouse and Human Protein Coding Gene Repetoires) in MGSCv3 if greater than 25% of its exonic sequence falls into any of these four categories.
Links to our gene catalogues and further details of these analyses can be found in Protocol S1 (Assembly Comparison and Analysis: Protein Coding Genes and Gene Families).
Identifying ancestral and derived ncRNAs.
We looked for evidence of human transcription for a set of known, mouse long ncRNAs  using human ESTs and RNA sequences from GenBank. The coordinates of all human ESTs and RNAs available from GenBank that mapped uniquely to regions outside of known protein-coding genes in the human genome (Ensembl v50; 384,861 sequences) were mapped onto the mouse Build 36 assembly using the human–mouse genome alignment data and the LiftOver tool from University of California Santa Cruz . We used default parameters and set the minimum ratio of mapped nucleotides to 0.2, which was appropriate for the human–mouse divergence. Of 145,321 sequences that map to the mouse assembly, only those found outside of known protein-coding genes in the mouse genome were considered for further analysis (96,367 human ESTs or RNAs). To identify candidate ancestral noncoding transcripts, we selected mouse ncRNAs from the previously described set of 3,051 mouse long noncoding genes that overlapped by one or more nucleotides these mapped human intergenic ESTs and RNAs. The statistical significance of this overlap was determined using a genome-wide association procedure that accounts for G+C-content and chromosomal biases . The statistical significance for the overlap between mouse non-coding RNAs and the annotated mouse repeat-derived sequence  were determined similarly, using mouse intergenic sequence as the null model. The significance of the increased fraction of overlapping sequence between repetitive elements and conserved over nonconserved mouse ncRNAs was determined using a Fisher's exact test.
Supporting figures, tables, and text. All supporting information can be found at the following Website: http://www.ncbi.nlm.nih.gov/projects/genome/guide/mouse/Build36_Publication_Supplement/.
(0.04 MB DOC)
The authors would like to thank the extended staff of all of the genome centres involved in this project. Without their hard work and dedication, this project would not have been possible.
The Mouse Genome Sequencing Consortium consists of the following members, displayed with their affiliations:
At the Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America; and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America: Donna M. Muzny, Shannon Dugan-Rocha, Yan Ding, Steven E. Scherer, Christian J. Buhay, Andrew Cree, Judith Hernandez, Michael Holder, Jennifer Hume, Laronda R. Jackson, Christie Kovar, Sandra L. Lee, Lora R. Lewis, Michael L. Metzker, Lynne V. Narareth, Aniko Sabo, Erica Sodergren, and Richard A. Gibbs.
At The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America: Michael C. Zody, Michael FitzGerald, April Cook, David B. Jaffe, Manuel Garber, Andrew R. Zimmer, Mono Pirun, Lyndsey Russell, Ted Sharpe, Michael Kamal-Kabir Chaturvedi, Jane Wilkinson, Kurt LaButti, Xiaoping Yang, Daniel Bessette, Nicole R. Allen, Cindy Nguyen, Thu Nguyen, Chelsea Dunbar, Rakela Lubonja, Charles Matthews, Xiaohong Liu, Mostafa Benamara, Tamrat Negash, Tashi Lokyitsang, Karin Decktor, Bruno Piqani, Glen Munson, Pema Tenzin, Sabrina Stone, Pendexter Macdonald, Harindra Arachchi, Amr Abouelleil, Annie Lui, Margaret Priest, Gary Gearin, Adam Brown, Lynne Aftuck, Terrance Shea, Sean Sykes, Aaron Berlin, Jeff Chu, Kathleen Dooley, Daniel Hagopian, Jennifer Hall, Nabil Hafez, Cherylyn L Smith, Peter Olandt, Karen Miller, Vijay Ventkataraman, Anthony Rachupka, Lester Dorris, III, Laura Ayotte, Richard Mabbitt, Jeffrey Erickson, Andrea Horn, Peter An, Jerome W. Naylor, Sampath Settipalli, The Broad Institute Genome Sequencing Platform, Broad Institute Genome Assembly Team, Eric S. Lander, and Kerstin Lindblad-Toh.
At The Genome Center at Washington University, St. Louis, Missouri, United States of America: Richard K. Wilson, Tina A. Graves, Robert S. Fulton, Susan M. Rock, LaDeana W. Hillier, Asif T. Chinwalla, Kelly Bernard, Laura P. Courtney, Catrina Fronick, Lucinda L. Fulton, Michelle O'Laughlin, Colin L. Kremitzki, Patrick J. Minx, Joanne O. Nelson, Kyriena L. Schatzkamer, Cynthia Strong, Aye M. Wollam, George M. Weinstock, and Shiaw-Pyng Yang.
At The Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom: Jane Rogers, Darren Grafham, Sean Humphray, Christine Nicholson, Christine Bird, Andrew J. Brown, John Burton, Chris Clee, Adrienne Hunt, Matt C. Jones, Christine Lloyd, Lucy Matthews, Karen Mclaren, Stuart Mclaren, Kirsten McLay, Sophie A Palmer, Robert Plumb, Ratna Shownkeen, Sarah Sims, Mike A Quail, Siobhan L. Whitehead, and David L. Willey.
Other sequence producers include the following:
At the University of Oklahoma Advanced Center for Genome Technology, Norman, Oklahoma, United States of America: Stephane Deschamps, Steven Kenton, Lin Song, Trang Do, and Bruce Roe.
At the National Institutes of Health Intramural Sequencing Center and Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America: NISC Comparative Sequencing Program, Gerard G. Bouffard, Robert W. Blakesley, and Eric D. Green.
At the Harvard Medical School Partners Healthcare Center for Genetics and Genomics, Boston, Massachusetts, United States of America: Raju Kucherlapati, George Grills, Li Li, and Kate T. Montgomery.
At the Lita Annenberg Hazen Genome Sequencing Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America: Melissa Kramer, Lori Speigel, and W. Richard McCombie.
At the Joint Genome Institute, US Department of Energy, Walnut Creek, California: Susan Lucas, Astrid Terry, Laurie Gordon, and Lisa Stubbs.
At Lawrence Livermore National Laboratory, Livermore, California, United States of America: Laurie Gordon, and Lisa Stubbs. Lisa Stubbs' current address is: Institute for Genomic Biology, University of Illinois, Urbana, Illinois, United States of America.
At the Medical Research Council Harwell, Mammalian Genetics Unit, Oxfordshire, United Kingdom: Paul Denny, Steve D. M. Brown, and Anne-Marie Mallon.
At the Medical Research Council Rosalind Franklin Centre for Genomics Research, Hinxton Genome Campus, United Kingdom: R. Duncan Campbell and Marc R. M. Botherby.
At the Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom: Ian J. Jackson.
At Agencourt Bioscience Corp, Beverly, Massachusetts, United States of America: Marc J. Rubenfield, Andrea M. Rogosin, and Douglas R. Smith.
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: DMC LG DCS KLT CPP. Performed the experiments: DMC LG LWH MZ SG XS CJB RA JLC MD WH YK PM DM ZB ACM TG SZ BT KP CC MP JH RR DF JAL ZC TMGSC. Analyzed the data: DMC LG LWH MZ SG XS CJB DCS ZC EEE CPP. Contributed reagents/materials/analysis tools: DMC LG. Wrote the paper: DMC LG LWH MZ KLT EEE CPP.
- 1. Murphy WJ, Pringle TH, Crider TA, Springer MS, Miller W (2007) Using genomic data to unravel the root of the placental mammal phylogeny. Genome Res 17: 413–421.
- 2. Rossant J, McKerlie C (2001) Mouse-based phenogenomics for modelling human disease. Trends Mol Med 7: 502–507.
- 3. Ohno S (1970) Evolution by gene duplication. New York: Springer-Verlag.
- 4. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, et al. (2002) Recent segmental duplications in the human genome. Science 297: 1003–1007.
- 5. She X, Cheng Z, Zöllner S, Church DM, Eichler EE (2008) Mouse segmental duplication and copy number variation. Nat Genet. 40: 909–914. doi:10.1038/ng.172.
- 6. Nguyen D, Webber C, Hehir-Kwa J, Pfundt R, Veltman J, et al. (2008) Reduced purifying selection prevails over positive selection in human copy number variant evolution. Genome Res 18: 1711–1723. doi:10.1101/gr.077289.108.
- 7. Bailey JA, Eichler EE (2006) Primate segmental duplications: crucibles of evolution, diversity and disease. Nat Rev Genet 7: 552–564. doi:10.1038/nrg1895.
- 8. Birtle Z, Goodstadt L, Ponting C (2005) Duplication and positive selection among hominin-specific PRAME genes. BMC Genomics 6: 120.
- 9. Laukaitis CM, Heger A, Blakley TD, Munclinger P, Ponting CP, et al. (2008) Rapid bursts of androgen-binding protein (Abp) gene duplication occurred independently in diverse mammals. BMC Evol. Biol 8: 46. doi:10.1186/1471-2148-8-46.
- 10. Jackson M, Watt AJ, Gautier P, Gilchrist D, Driehaus J, et al. (2006) A murine specific expansion of the Rhox cluster involved in embryonic stem cell biology is under natural selection. BMC Genomics 7: 212. doi:10.1186/1471-2164-7-212.
- 11. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520–562.
- 12. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, et al. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493–521.
- 13. (2005) Initial sequence of the chimpanzee genome and comparison with the human genome Nature 437: 69–87.
- 14. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al. (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438: 803–819.
- 15. Mikkelsen TS, Wakefield MJ, Aken B, Amemiya CT, Chang JL, et al. (2007) Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences. Nature 447: 167–177.
- 16. Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, et al. (2007) Evolutionary and biomedical insights from the rhesus macaque genome. Science 316: 222–234.
- 17. She X, Jiang Z, Clark RA, Liu G, Cheng Z, et al. (2004) Shotgun sequence assembly and recent segmental duplications within the human genome. Nature 431: 927–930.
- 18. Bailey JA, Church DM, Ventura M, Rocchi M, Eichler EE (2004) Analysis of segmental duplications and genome assembly in the mouse. Genome Res 14: 789–801.
- 19. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931–945.
- 20. Pevzner P, Tesler G (2003) Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution. Proc Natl Acad Sci U S A 100: 7672–7677. doi:10.1073/pnas.1330369100.
- 21. Armengol L, Pujana MA, Cheung J, Scherer SW, Estivill X (2003) Enrichment of segmental duplications in regions of breaks of synteny between the human and mouse genomes suggest their involvement in evolutionary rearrangements. Hum Mol Genet 12: 2201–2208. doi:10.1093/hmg/ddg223.
- 22. Chittenden L, Lu X, Cacheiro NLA, Cain KT, Generoso W, et al. (2002) A new mouse model for autosomal recessive polycystic kidney disease. Genomics 79: 499–504. doi:10.1006/geno.2002.6731.
- 23. Murphy WJ, Agarwala R, Schäffer AA, Stephens R, Smith C, et al. (2005) A rhesus macaque radiation hybrid map and comparative analysis with the human genome. Genomics 86: 383–295. doi:10.1016/j.ygeno.2005.05.013.
- 24. She X, Jiang Z, Clark RA, Liu G, Cheng Z, et al. (2004) Shotgun sequence assembly and recent segmental duplications within the human genome. Nature 431: 927–930. doi:10.1038/nature03062.
- 25. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. (2001) The sequence of the human genome. Science 291: 1304–1351.
- 26. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, et al. (2006) Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet 2: e2. doi:10.1371/journal.pgen.0020002.
- 27. Whitelaw E, Martin DI (2001) Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 27: 361–365. doi:10.1038/86850.
- 28. Marques-Bonet T, Kidd JM, Ventura M, Graves TA, Cheng Z, et al. (2009) A burst of segmental duplications in the genome of the African great ape ancestor. Nature 457: 877–481. doi:10.1038/nature07744.
- 29. National Center for Biotechnology Information. NCBI Annotation Information Available: http://www.ncbi.nlm.nih.gov/projects/genome/guide/build.shtml. Accessed 24 February 2009.
- 30. Ensembl. Gene Annotation Available: http://www.ensembl.org/info/docs/genebuild/index.html. Accessed 24 February 2009.
- 31. Huang H, Winter EE, Wang H, Weinstock KG, Xing H, et al. (2004) Evolutionary conservation and selection of human disease gene orthologs in the rat and mouse genomes. Genome Biol 5: R47.
- 32. Goodstadt L, Ponting CP (2006) Phylogenetic reconstruction of orthology, paralogy, and conserved synteny for dog and human. PLoS Comput Biol 2: e133. doi:10.1371/journal.pcbi.0020133.
- 33. Goodstadt L, Heger A, Webber C, Ponting CP (2007) An analysis of the gene complement of a marsupial, Monodelphis domestica: evolution of lineage-specific genes and giant chromosomes. Genome Res 17: 969–981.
- 34. Clamp M, Fry B, Kamal M, Xie X, Cuff J, et al. (2007) Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci U S A 104: 19428–19433. doi:10.1073/pnas.0709013104.
- 35. Rouquier S, Blancher A, Giorgi D (2000) The olfactory receptor gene repertoire in primates and mouse: evidence for reduction of the functional fraction in primates. Proc Natl Acad Sci U S A 97: 2870–2874.
- 36. Young JM, Kambere M, Trask BJ, Lane RP (2005) Divergent V1R repertoires in five species: Amplification in rodents, decimation in primates, and a surprisingly small repertoire in dogs. Genome Res 15: 231–240.
- 37. Liman ER, Innan H (2003) Relaxed selective pressure on an essential component of pheromone transduction in primate evolution. Proc Natl Acad Sci U S A 100: 3328–3332.
- 38. Emes RD, Riley MC, Laukaitis CM, Goodstadt L, Karn RC, et al. (2004) Comparative evolutionary genomics of androgen-binding protein genes. Genome Res 14: 1516–1529.
- 39. Jacobs LL, Downs WR (1994) The evolution of murine rodents in Asia. Nat Sci Museum Monographs 8: 149–156.
- 40. Abd El-Aziz MM, Barragan I, O'Driscoll CA, Goodstadt L, Prigmore E, et al. (2008) EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat Genet. 40: 1285–1287.
- 41. Söderlund D, Canto P, Méndez JP (2002) Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome. J Clin Endocrinol Metab 87: 2589–2592.
- 42. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, et al. (2005) The DNA sequence of the human X chromosome. Nature 434: 325–337.
- 43. Perry J, Palmer S, Gabriel A, Ashworth A (2001) A short pseudoautosomal region in laboratory mice. Genome Res 11: 1826–1832.
- 44. Kipling D, Wilson HE, Thomson EJ, Lee M, Perry J, et al. (1996) Structural variation of the pseudoautosomal region between and within inbred mouse strains. Proc Natl Acad Sci U S A 93: 171–175.
- 45. Bolliger MF, Pei J, Maxeiner S, Boucard AA, Grishin NV, et al. (2008) Unusually rapid evolution of Neuroligin-4 in mice. Proc Natl Acad Sci U S A 105: 6421–6426. doi:10.1073/pnas.0801383105.
- 46. Salido EC, Li XM, Yen PH, Martin N, Mohandas TK, et al. (1996) Cloning and expression of the mouse pseudoautosomal steroid sulphatase gene (Sts). Nat Genet 13: 83–86. doi:10.1038/ng0596-83.
- 47. Spiess A, Walther N, Müller N, Balvers M, Hansis C, et al. (2003) SPEER–a new family of testis-specific genes from the mouse. Biol Reprod 68: 2044–2054.
- 48. Iida H, Ichinose J, Kaneko T, Mōri T, Shibata Y (2004) Complementary DNA cloning of rat spetex-1, a spermatid-expressing gene-1, encoding a 63 kDa cytoplasmic protein of elongate spermatids. Mol Reprod Dev 68: 385–393.
- 49. Tu S, Shin Y, Zago WM, States BA, Eroshkin A, et al. (2007) Takusan: a large gene family that regulates synaptic activity. Neuron 55: 69–85.
- 50. Dadé S, Callebaut I, Mermillod P, Monget P (2003) Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte. FEBS Lett 555: 533–538.
- 51. Lammers JHM, Offenberg HH, Van Aalderen M, Vink ACG, Dietrich AJJ, et al. (1994) : The gene encoding a major component of synaptonemal complexes of rat is related to X-linked lymphocyte-regulated genes. Mol Cell Biol; 14: 1137–1146.
- 52. Oh B, Hwang SY, Solter D, Knowles BB (1997) : Spindlin, a major maternal transcript expressed in the mouse during the transition from oocyte to embryo. Development, 124: 493–503.
- 53. Reynard LN, Turner JM, Cocquet J, Mahadevaiah SK, Touré A, et al. (2007) : Expression analysis of the mouse multi-copy X-linked gene Xlr-related, meiosis-regulated (Xmr), reveals that Xmr encodes a spermatid-expressed cytoplasmic protein, SLX/XMR. Biol Reprod, 77: 329–35. doi:10.1095/biolreprod.107.061101.
- 54. Touré A, Grigoriev V, Mahadevaiah SK, Rattigan A, Ojarikre OA, et al. (2004) : A protein encoded by a member of the multicopy Ssty gene family located on the long arm of the mouse Y chromosome is expressed during sperm development. Genomics 83: 140–147. doi:10.1016/S0888-7543(03)00216-7.
- 55. Charlesworth B, Coyne JA, Barton (1987) : The Relative Rates of Evolution of Sex Chromosomes and Autosomes. N. Am. Nat. 130: 113–146. doi:10.1086/284701.
- 56. Ellis PJI, Clemente EJ, Ball P, Touré A, Ferguson L, et al. (2005) Deletions on mouse Yq lead to upregulation of multiple X- and Y-linked transcripts in spermatids. Hum Mol Genet 14: 2705–2715. doi:10.1093/hmg/ddi304.
- 57. Mueller JL, Mahadevaiah SK, Park PJ, Warburton PE, Page DC, et al. (2008) : The mouse X chromosome is enriched for multicopytestis genes showing postmeiotic expression. Nat Genet. 40: 794–799. doi:10.1038/ng.126.
- 58. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, et al. (2003) The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423: 825–837.
- 59. Emes RD, Goodstadt L, Winter EE, Ponting CP (2003) Comparison of the genomes of human and mouse lays the foundation of genome zoology. Hum Mol Genet 12: 701–709.
- 60. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154–8. doi:10.1093/nar/gkm952.
- 61. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, et al. (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420: 563–573. doi:10.1038/nature01266.
- 62. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. (2005) The transcriptional landscape of the mammalian genome. Science 309: 1559–1563.
- 63. Ponjavic J, Ponting CP, Lunter G (2007) Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 17: 556–565. doi:10.1101/gr.6036807.
- 64. Stevens JC, Banks GT, Festing MFW, Fisher EMC (2007) Quiet mutations in inbred strains of mice. Trends Mol Med 13: 512–519. doi:10.1016/j.molmed.2007.10.001.
- 65. Grubb SC, Maddatu TP, Bult CJ, Bogue MA (2009) Mouse phenome database. Nucleic Acids Res 37: D720–30. doi:10.1093/nar/gkn778.
- 66. Justice MJ (2000) Capitalizing on large-scale mouse mutagenesis screens. Nat Rev Genet 1: 109–115.
- 67. Collins FS, Finnell RH, Rossant J, Wurst W (2007) A new partner for the international knockout mouse consortium. Cell 129: 235.
- 68. Nicholas TJ, Cheng Z, Ventura M, Mealey K, Eichler EE, et al. (2009) The genomic architecture of segmental duplications and associated copy number variants in dogs. Genome Res 19: 491–799.
- 69. Eid J, Fehr A, Gray J, Luong K, Lyle J, et al. (2009) Real-time DNA sequencing from single polymerase molecules. Science 323: 133–138. doi:10.1126/science.1162986.
- 70. Varki A, Altheide TK (2005) Comparing the human and chimpanzee genomes: searching for needles in a haystack. Genome Res 15: 1746–1758. doi:10.1101/gr.3737405.
- 71. Martin RD (2003) Human reproduction: a comparative background for medical hypotheses. J Reprod Immunol 59: 111–135.
- 72. Knockout Mouse Project (KOMP) ::Home Available: http://www.knockoutmouse.org/. Accessed 24 February 2009.
- 73. BAC Clones distribution center - BACPAC Resources Center Available: http://bacpac.chori.org/. Accessed 24 February 2009.
- 74. Gregory SG, Sekhon M, Schein J, Zhao S, Osoegawa K, et al. (2002) A physical map of the mouse genome. Nature 418: 743–750.
- 75. Aluru S (2005) Handbook of computational molecular biology. 1st ed. Boca Raton (Florida): Chapman & Hall/CRC.
- 76. RepeatMasker Home Page. Available: http://www.repeatmasker.org/. Accessed 24 February 2009.
- 77. Morgulis A, Gertz EM, Schäffer AA, Agarwala R (2006) WindowMasker: window-based masker for sequenced genomes. Bioinformatics 22: 134–141.
- 78. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403–410. doi:10.1006/jmbi.1990.9999.
- 79. Lift Genome Annotations Available: http://genome.ucsc.edu/cgi-bin/hgLiftOver. Accessed 24 February 2009.
- 80. ftp://hgdownload.cse.ucsc.edu/apache/htdocs/goldenPath/mm8/database/ Accessed 24 February 2009.
- 81. Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, et al. (1996) A comprehensive genetic map of the mouse genome. Nature 380: 149–152.
- 82. Hudson TJ, Church DM, Greenaway S, Nguyen H, Cook A, et al. (2001) A radiation hybrid map of mouse genes. Nat Genet 29: 201–205.
- 83. Pruitt KD, Tatusova T, Maglott DR (2007) NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 35: D61–5.
- 84. Dimalanta ET, Lim A, Runnheim R, Lamers C, Churas C, et al. (2004) A microfluidic system for large DNA molecule arrays. Anal Chem 76: 5293–5301. doi:10.1021/ac0496401.
- 85. Zhou S, Bechner MC, Place M, Churas CP, Pape L, et al. (2007) Validation of rice genome sequence by optical mapping. BMC Genomics 8: 278. doi:10.1186/1471-2164-8-278.
- 86. Valouev A, Li L, Liu Y, Schwartz DC, Yang Y, et al. (2006) Alignment of optical maps. J Comput Biol 13: 442–462. doi:10.1089/cmb.2006.13.442.